Find a TenderCancelledProcurement termination notice
Published 12 Aug 2025, 10:18 BST

Official UK procurement notice

Helix Biotech Biosimilar mRNA Vaccines

Official notice

Authority: Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency (Central government)

Direct awardSME suitableVCSE suitable
Sectors: Medical Devices & Pharma (33) Delivery: Delivery location not published
Budget not disclosedValue not published
Submission deadline Not published

What is being bought

Published requirement description

Vaccine mimic materials-comprising messenger RNA (mRNA) and lipid nanoparticles (LNPs)-from Helix-Biotech.

The lotProcurement structure

single lot · no lot value published
Lot #1AwardedSMEVCSE
Eligibility: SME eligibleVCSE eligible

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Cancelled
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Competitive procedure
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
12 Aug 2025, 10:18 BST
Last source update
4 Sept 2025, 13:41 BST
Authority reference
C371747
FTS notice number
2025/S 000-053927
Latest notice
Procurement termination notice (UK12)
Delivery area
Not published
Official registry OCID
ocds-h6vhtk-0585bd Find a Tender
Why no open competition
Single Suppliers Technical Reasons
Published justification

Helix-Biotech Inc. is the only supplier capable of delivering the required vaccine mimic materials (mRNA encapsulated in LNPs) with validated equivalence to licensed Pfizer-style COVID-19 vaccines. Their proprietary methodology and formulation capability are not available from other suppliers, nor covered under any current public procurement frameworks.

Review and risk notes
Risks

A valid and current Cyber Essentials Certificate is required.

Notice history

3 events · 2 releases on Find a Tender · since 12 Aug 2025
  1. Transparency notice published
    12 Aug 2025, 10:18 BST
    UK5
  2. Contract signature expected
    1 Sept 2025, 23:59 BST
    scheduled
  3. Procurement termination notice published
    4 Sept 2025, 13:41 BST
    UK12

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1
Awarded toValueDateStatus
Helix Biotech Inc.8 Sept 2025 – 7 Sept 2027£150,0002 Sept 2025CancelledWe are currently unable to modify the description on the Transparency Notice and therefore a termination notice has been issued for this procedure and a new UK5 Transparency Notice will be published with a modified description.

Contracting authority & participating public bodies

UK Health Security Agency

Contracting authorityPublic authority - central government GB-PPON: PBMQ-7576-DVGW 10 South Colonnade, London, London, E14 4PUContact email

Bidders & participating suppliers

1 commercial party on the notice
  • Helix Biotech, Inc.Awarded supplierGB-PPON: PCMD-6995-GBGZ 1460 Breda Drive, Knoxville, US, 37918, USContact email

Official documents & specifications (2)

Official links; attachments are not copied

Notices published for this procedure